Form 4: PepGen Inc. Chief Medical Officer Michelle Mellion Executes Stock Options and Sells Shares Under 10b5-1 Plan

Michelle Mellion, Chief Medical Officer of PepGen Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Michelle Mellion, the Chief Medical Officer of PepGen Inc., executed stock options to purchase shares of common stock at a price of $10.21.
• She then sold these shares on July 12, 2024, and July 16, 2024, at a weighted average price of approximately $18.04 and $18.00, respectively.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on January 19, 2024.
• The sales resulted in Mellion holding 0 shares of common stock directly.
• Following these transactions, Mellion continues to hold 70,397 stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, as it's simply a record of stock option exercises and sales.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 trading plan suggests that the transactions were pre-planned and not based on any material non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares in the open market.

Key Dates